Acute Crit Care.  2024 May;39(2):282-293. 10.4266/acc.2024.00612.

The efficacy of therapeutic hypothermia in patients with poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

Affiliations
  • 1Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 2Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
  • 3Bio-Medical Institute of Technology, University of Ulsan College of Medicine, Seoul, Korea
  • 4Department of Neurosurgery, Dongsan Medical Center, Keimyung University College of Medicine, Daegu, Korea
  • 5Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Abstract

Background
This study evaluates the effectiveness of Therapeutic Hypothermia (TH) in treating poor-grade aneurysmal subarachnoid hemorrhage (SAH), focusing on functional outcomes, mortality, and complications such as vasospasm, delayed cerebral ischemia (DCI), and hydrocephalus. Methods: Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a comprehensive literature search was conducted across multiple databases, including Medline, Embase, and Cochrane Central, up to November 2023. Nine studies involving 368 patients were selected based on eligibility criteria focusing on TH in poor-grade SAH patients. Data extraction, bias assessment, and evidence certainty were systematically performed. Results: The primary analysis of unfavorable outcomes in 271 participants showed no significant difference between the TH and standard care groups (risk ratio [RR], 0.87). However, a significant reduction in vasospasm was observed in the TH group (RR, 0.63) among 174 participants. No significant differences were found in DCI, hydrocephalus, and mortality rates in the respective participant groups. Conclusions: TH did not significantly improve primary unfavorable outcomes in poor-grade SAH patients. However, the reduction in vasospasm rates indicates potential specific benefits. The absence of significant findings in other secondary outcomes and mortality highlights the need for further research to better understand TH's role in treating this patient population.

Keyword

hypothermia; intracranial vasospasm; mortality; stroke; subarachnoid hemorrhage

Figure

  • Figure 1. The flow diagram of the literature search. SAH: subarachnoid hemorrhage.

  • Figure 2. Forest plot of studies comparing unfavorable functional outcomes in the therapeutic hypothermia group with that in the control group. The horizontal bars represent 95% confidence intervals (CIs).

  • Figure 3. Forest plot of studies comparing the subarachnoid hemorrhage related complication and mortality in the therapeutic hypothermia group with that in the control group. (A) Fours studies reported vasospasm. The meta-analysis of risk ratio reported a statistically lower incidence of vasospasm in patients treated with therapeutic hypothermia. (B) Three studies reported delayed cerebral ischemia. There was no significant effect involving therapeutic hypothermia and delayed cerebral ischemia. (C) Three studies reported hydrocephalus. There was no significant effect involving therapeutic hypothermia and hydrocephalus. (D) Fives studies reported mortality. There was no significant effect involving therapeutic hypothermia and mortality. CI: confidence interval.


Reference

1. Panchal AR, Bartos JA, Cabañas JG, Donnino MW, Drennan IR, Hirsch KG, et al. Part 3: adult basic and advanced life support. 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020; 142(16_suppl_2):S366–468.
2. Choi HA, Badjatia N, Mayer SA. Hypothermia for acute brain injury: mechanisms and practical aspects. Nat Rev Neurol. 2012; 8:214–22.
Article
3. Jackson TC, Kochanek PM. A new vision for therapeutic hypothermia in the era of targeted temperature management: a speculative synthesis. Ther Hypothermia Temp Manag. 2019; 9:13–47.
Article
4. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009; 37:S186–202.
Article
5. Schreckinger M, Marion DW. Contemporary management of traumatic intracranial hypertension: is there a role for therapeutic hypothermia? Neurocrit Care. 2009; 11:427–36.
Article
6. Chen H, Wu F, Yang P, Shao J, Chen Q, Zheng R. A meta-analysis of the effects of therapeutic hypothermia in adult patients with traumatic brain injury. Crit Care. 2019; 23:396.
Article
7. Yao Z, You C, He M. Effect and feasibility of therapeutic hypothermia in patients with hemorrhagic stroke: a systematic review and meta-analysis. World Neurosurg. 2018; 111:404–12.
8. Baker TS, Durbin J, Troiani Z, Ascanio-Cortez L, Baron R, Costa A, et al. Therapeutic hypothermia for intracerebral hemorrhage: systematic review and meta-analysis of the experimental and clinical literature. Int J Stroke. 2022; 17:506–16.
Article
9. Kuczynski AM, Marzoughi S, Al Sultan AS, Colbourne F, Menon BK, van Es AC, et al. Therapeutic hypothermia in acute ischemic stroke-a systematic review and meta-analysis. Curr Neurol Neurosci Rep. 2020; 20:13.
Article
10. Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023; 54:e314–70.
Article
11. Sterne JA, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898.
Article
12. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919.
Article
13. Muroi C, Frei K, El Beltagy M, Cesnulis E, Yonekawa Y, Keller E. Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008; 20:193–8.
Article
14. Neuman E, Smrčka M, Gál R, Jura R. Mild controlled hypothermia: a neuroprotective method for late ischaemic complications in resuscitation care for patients with severe spontaneous subarachnoid hemorrhage caused by aneurysm rupture. Ceska Slovenska Neurologie Neurochirurgie. 2008; 71:180–7.
15. Anei R, Sakai H, Iihara K, Nagata I. Effectiveness of brain hypothermia treatment in patients with severe subarachnoid hemorrhage: comparisons at a single facility. Neurol Med Chir (Tokyo). 2010; 50:879–83.
16. Karnatovskaia LV, Lee AS, Festic E, Kramer CL, Freeman WD. Effect of prolonged therapeutic hypothermia on intracranial pressure, organ function, and hospital outcomes among patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014; 21:451–61.
Article
17. Kuramatsu JB, Kollmar R, Gerner ST, Madžar D, Pisarčíková A, Staykov D, et al. Is hypothermia helpful in severe subarachnoid hemorrhage? An exploratory study on macro vascular spasm, delayed cerebral infarction and functional outcome after prolonged hypothermia. Cerebrovasc Dis. 2015; 40:228–35.
Article
18. Choi W, Kwon SC, Lee WJ, Weon YC, Choi B, Lee H, et al. Feasibility and safety of mild therapeutic hypothermia in poor-grade subarachnoid hemorrhage: prospective pilot study. J Korean Med Sci. 2017; 32:1337–44.
Article
19. Shui T, Guo ZY, Zhang GZ, Chen Q, Li B. Effect and significance of mild hypothermia on cerebral blood flow velocity and cerebral extraction rate of oxygen in patients with severe subarachnoid hemorrhage. Zhonghua Yi Xue Za Zhi. 2018; 98:1489–92.
20. Rhim JK, Park JJ, Kim H, Jeon JP. Early and prolonged mild hypothermia in patients with poor-grade subarachnoid hemorrhage: a pilot study. Ther Hypothermia Temp Manag. 2022; 12:229–34.
Article
21. Won SY, Kim MK, Song J, Lim YC. Therapeutic hypothermia in patients with poor-grade aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2022; 221:107369.
Article
22. Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015; 373:2403–12.
Article
23. Neugebauer H, Schneider H, Bösel J, Hobohm C, Poli S, Kollmar R, et al. Outcomes of hypothermia in addition to decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial. JAMA Neurol. 2019; 76:571–9.
Article
24. Maekawa T, Yamashita S, Nagao S, Hayashi N, Ohashi Y, Brain-Hypothermia Study Group. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury: a randomized controlled trial. J Neurotrauma. 2015; 32:422–9.
Article
25. Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011; 10:131–9.
Article
26. Su Y, Fan L, Zhang Y, Zhang Y, Ye H, Gao D, et al. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction. Stroke. 2016; 47:457–63.
Article
27. Kim JH, Nagy Á, Putzu A, Belletti A, Biondi-Zoccai G, Likhvantsev VV, et al. Therapeutic hypothermia in critically ill patients: a systematic review and meta-analysis of high quality randomized trials. Crit Care Med. 2020; 48:1047–54.
Article
28. Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke. 2008; 39:3242–7.
Article
29. Lord AS, Karinja S, Lantigua H, Carpenter A, Schmidt JM, Claassen J, et al. Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocrit Care. 2014; 21:200–6.
Article
30. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009; 40:e657–65.
31. Kupchik NL. Development and implementation of a therapeutic hypothermia protocol. Crit Care Med. 2009; 37:S279–84.
Article
32. Choi HA, Ko SB, Presciutti M, Fernandez L, Carpenter AM, Lesch C, et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care. 2011; 14:389–94.
Article
33. Tan L, Yao D. Meta-analysis for the prognosis of subarachnoid hemorrhage treated with mild hypothermia. Asian J Surg. 2023; 46:5674–6.
Article
34. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Cochrane;2008.
Full Text Links
  • ACC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr